Clinical Trial Update: Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating a mitochondrial-targeted antioxidant supplement to improve age-related vascular dysfunct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging

Drugs mentioned

• Mitochondrial-targeted antioxidant supplement

Snippet

Sponsor: University of Colorado, Boulder | Conditions: Aging | Phase 2 | Status: ACTIVE_NOT_RECRUITING